PRIMARY CARBOXAMIDES AS BTK INHIBITORS

The invention provides compounds of Formula (I)pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.

Saved in:
Bibliographic Details
Main Authors FRIEDMAN, MICHAEL, M, WALLACE, GRIER, A, HOEMANN, MICHAEL, Z, HUNTLEY, RAYMOND, FRANK, KRISTINE, E, WILSON, NOEL, S, WANG, ZHI, SHEPPARD, GEORGE, VAN CAMP, JENNIFER, WANG, LU, DAVIS, HEATHER, M, OSUMA, AUGUSTINE, VASUDEVAN, ANIL, BONAFOUX, DOMINIQUE, XU, XIANGDONG, HEROLD, J., MARTIN, SOMAL, GAGANDEEP, K, VAN EPPS, STACY, A
Format Patent
LanguageEnglish
Serbian
Published 29.03.2019
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

Abstract The invention provides compounds of Formula (I)pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.
AbstractList The invention provides compounds of Formula (I)pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.
Author SHEPPARD, GEORGE
VAN CAMP, JENNIFER
WALLACE, GRIER, A
WILSON, NOEL, S
XU, XIANGDONG
OSUMA, AUGUSTINE
SOMAL, GAGANDEEP, K
WANG, LU
HOEMANN, MICHAEL, Z
VAN EPPS, STACY, A
FRANK, KRISTINE, E
FRIEDMAN, MICHAEL, M
VASUDEVAN, ANIL
HUNTLEY, RAYMOND
BONAFOUX, DOMINIQUE
DAVIS, HEATHER, M
HEROLD, J., MARTIN
WANG, ZHI
Author_xml – fullname: FRIEDMAN, MICHAEL, M
– fullname: WALLACE, GRIER, A
– fullname: HOEMANN, MICHAEL, Z
– fullname: HUNTLEY, RAYMOND
– fullname: FRANK, KRISTINE, E
– fullname: WILSON, NOEL, S
– fullname: WANG, ZHI
– fullname: SHEPPARD, GEORGE
– fullname: VAN CAMP, JENNIFER
– fullname: WANG, LU
– fullname: DAVIS, HEATHER, M
– fullname: OSUMA, AUGUSTINE
– fullname: VASUDEVAN, ANIL
– fullname: BONAFOUX, DOMINIQUE
– fullname: XU, XIANGDONG
– fullname: HEROLD, J., MARTIN
– fullname: SOMAL, GAGANDEEP, K
– fullname: VAN EPPS, STACY, A
BookMark eNrjYmDJy89L5WRQCwjy9HUMilRwdgxy8o9w9PV0cQ1WcAxWcArxVvD08_B08gzxDwrmYWBNS8wpTuWF0twMcm6uIc4euqkF-fGpxQWJyal5qSXxQcGmFkbmxk6GxgQVAADc6CRJ
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate PRIMARNI KARBOKSAMIDI KAO BTK INHIBITORI
ExternalDocumentID RS58273B1
GroupedDBID EVB
ID FETCH-epo_espacenet_RS58273B13
IEDL.DBID EVB
IngestDate Fri Jul 19 14:41:15 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
Serbian
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_RS58273B13
Notes Application Number: RS2019P000083
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190329&DB=EPODOC&CC=RS&NR=58273B1
ParticipantIDs epo_espacenet_RS58273B1
PublicationCentury 2000
PublicationDate 20190329
PublicationDateYYYYMMDD 2019-03-29
PublicationDate_xml – month: 03
  year: 2019
  text: 20190329
  day: 29
PublicationDecade 2010
PublicationYear 2019
RelatedCompanies ABBVIE INC
RelatedCompanies_xml – name: ABBVIE INC
Score 3.1946557
Snippet The invention provides compounds of Formula (I)pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Title PRIMARY CARBOXAMIDES AS BTK INHIBITORS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190329&DB=EPODOC&locale=&CC=RS&NR=58273B1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1JT4QwFH6ZjEa96bgvEw6GG5Gwz4EYKBDQsKSgwdOEApl40cmA8e_7Shj1MremTbq89OvXr-17BbhfGJZumihTLeQGSWvkVmK1qkiahWBCgsRZws8h48QIX7SnUi8nsNr6wgxxQr-H4IiIqBrx3g_r9frvEMsb3lZ2D-wdsz4fg8L2xFEdI7upKKA91_az1EuJSIhNczGhtm4hT7sok_ZwD21yKPivLndJWf_nk-AY9jOs6qM_gUm3mcEh2X67NoODeLztxuQIvO4UxIxGsUPfBOJQNy2dOPL8XHBywS2ehSgJIzcqUpqfwTzwCxJK2ODyd2hLmo8dU89hinq_vQShMptKqSqZKXwzY2hM1mpmyXrLQ9tVVnMFFzsqud5ZcgNH3Dr88ZSyuIVpv_lq75BNezYfLPEDYHF1Yw
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3JTsMwEB1VBVFuUPal5IByi4jSLO4hQlmV0GaRE1A4RdmEuEDVBPH7jKMUuPRm2ZKXkZ-fn-0ZA9wvVKJoGspUgtwgyLXYCGU1lwSZIJiQIHGWsHPIIFS9Z_kpU7IRvG19Yfo4od99cEREVIV47_r1ev13iGX3byvbh_Idsz4f3VS3-UEdI7vNUUDbpu7EkR1ZvGXpNOFDqisEedpEmbSH-2uNQcF5MZlLyvo_n7hHsB9jVR_dMYzazRQm1vbbtSkcBMNtNyYH4LUnwMfUDwz6ylkGNaPMCHzbSTgj4cx0yfmh55t-GtHkFGauk1qegA3mv0PLaTJ0bH4GY9T7zQVwhVYXUlGIpcQ2M6pcinJVElFpWGi7gtSXcL6jkqudJXcw8dJgla_8cHkNh8xS7CGVtLiBcbf5am6RWbty1lvlBwvfeFY
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=PRIMARY+CARBOXAMIDES+AS+BTK+INHIBITORS&rft.inventor=FRIEDMAN%2C+MICHAEL%2C+M&rft.inventor=WALLACE%2C+GRIER%2C+A&rft.inventor=HOEMANN%2C+MICHAEL%2C+Z&rft.inventor=HUNTLEY%2C+RAYMOND&rft.inventor=FRANK%2C+KRISTINE%2C+E&rft.inventor=WILSON%2C+NOEL%2C+S&rft.inventor=WANG%2C+ZHI&rft.inventor=SHEPPARD%2C+GEORGE&rft.inventor=VAN+CAMP%2C+JENNIFER&rft.inventor=WANG%2C+LU&rft.inventor=DAVIS%2C+HEATHER%2C+M&rft.inventor=OSUMA%2C+AUGUSTINE&rft.inventor=VASUDEVAN%2C+ANIL&rft.inventor=BONAFOUX%2C+DOMINIQUE&rft.inventor=XU%2C+XIANGDONG&rft.inventor=HEROLD%2C+J.%2C+MARTIN&rft.inventor=SOMAL%2C+GAGANDEEP%2C+K&rft.inventor=VAN+EPPS%2C+STACY%2C+A&rft.date=2019-03-29&rft.externalDBID=B1&rft.externalDocID=RS58273B1